Form 4: Bone Biologics Corp Director Acquires Stock Options
SEC Form 4 Filing
Bruce Stroever, a director of Bone Biologics Corp, reports the acquisition of stock options.
Summary
- On September 19, 2024, Bruce Stroever, a director of Bone Biologics Corp, filed a Form 4.
- The form details changes in his beneficial ownership of securities.
- The earliest transaction date reported is September 17, 2024.
- Stroever acquired 30,713 non-employee stock options with an exercise price of $1.73.
- These options vest and become exercisable quarterly through the date of the next annual meeting of stockholders.
- He also holds other non-employee stock options with varying exercise prices and expiration dates.
Sentiment
Score: 5
Explanation: This is a routine filing, indicating standard insider activity. It doesn't inherently suggest positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The acquisition of stock options by a director could be viewed positively by shareholders as it aligns the director's interests with the company's performance.
Key Dates
| Date | Description |
|---|---|
| 08/23/2027 | Expiration date for Non-Employee Stock Option with exercise price of $387.26 |
| 01/01/2032 | Expiration date for Non-Employee Stock Option with exercise price of $844.8 |
| 10/26/2031 | Expiration date for Non-Employee Stock Option with exercise price of $1,260 |
| 09/13/2033 | Expiration date for Non-Employee Stock Option with exercise price of $5.12 |
| 09/17/2024 | Date of earliest transaction and grant date of 30,713 stock options at $1.73 |
| 09/17/2034 | Expiration date for Non-Employee Stock Option with exercise price of $1.73 |
| 09/19/2024 | Date of Form 4 filing |
Keywords
Form 4, Stock Options, Beneficial Ownership, Director, Bone Biologics Corp, BBLG, Securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.